Recognition, diagnosis and referral of patients with Dupuytren's disease: A review of current concepts for general practitioners in Europe

Current Medical Research and Opinion

Volumn 29, Issue 3, 2013, Pages 269-277

  Van Dijk, Dilaine ^a   Finigan, Peter ^b   Gerber, Robert A ^c   Szczypa, Piotr P ^d   Werker, Paul M N ^e  

^a not available   (Netherlands)

^b Brookfield Surgery   (United Kingdom)

^c PFIZER INC   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Algorithm; Diagnosis; Dupuytren's disease; Primary care physicians; Referrals

Indexed keywords

CLOSTRIDIOPEPTIDASE A; PLACEBO;

ARTERY INJURY; CLINICAL FEATURE; COMPLEX REGIONAL PAIN SYNDROME; COMPLEX REGIONAL PAIN SYNDROME TYPE I; COMPLEX REGIONAL PAIN SYNDROME TYPE II; DIFFERENTIAL DIAGNOSIS; DUPUYTREN CONTRACTURE; EUROPE; FASCIOTOMY; FOLLOW UP; GENERAL PRACTITIONER; HAND; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; INJECTION SITE CONTUSION; INJECTION SITE PAIN; INJECTION SITE SWELLING; MINIMALLY INVASIVE PROCEDURE; NERVE INJURY; PATHOPHYSIOLOGY; PATIENT REFERRAL; PERCUTANEOUS NEEDLE FASCIOTOMY; POSTOPERATIVE COMPLICATION; PREVALENCE; QUALITY OF LIFE; RANGE OF MOTION; REVIEW; RISK FACTOR; SURGEON; TENDON RUPTURE; TREATMENT OUTCOME;

EID: 84873663131     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2013.766163     Document Type: Review

References (46)

1. Townley WA, Baker R, Sheppard N, et al. Dupuytren's contracture unfolded. BMJ 2006;332:397-400
2. Bayat A, Cunliffe EJ, McGrouther DA. Assessment of clinical severity in Dupuytren's disease. Br J Hosp Med (Lond) 2007;68:604-9
3. Bayat A, McGrouther DA. Management of Dupuytren's disease-clear advice for an elusive condition. Ann R Coll Surg Engl 2006;88:3-8
4. Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand 2009;4:256-69
5. Ross DC. Epidemiology of Dupuytren's disease. Hand Clin 1999;15:53-62
6. Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg Br 1999;24:456-9
7. Khan AA, Rider OJ, Jayadev CU, et al. The role of manual occupation in the aetiology of Dupuytren's disease in men in England and Wales. J Hand Surg Br 2004;29:12-14
8. Wildin C, Dias JJ, Heras-Palou C, et al. Trends in elective hand surgery referrals from primary care. Ann R Coll Surg Engl 2006;88:543-6
9. Rayan GM. Palmar fascial complex anatomy and pathology in Dupuytren's disease. Hand Clin 1999;15:73-86, vi-vii
10. Rayan GM. Dupuytren disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am 2007;89:189-98
11. Figus A, Britto JA, Ragoowansi RH, et al. A clinical analysis of Dupuytren's disease of the thumb. J Hand Surg Eur 2008;33:272-9
12. Milner RH. Dupuytren's disease affecting the thumb and first web of the hand. J Hand Surg Br 2003;28:33-6
13. Hayton M, Manning C. Dupuytren's disease. Geriatric Med 2011;451-5
14. Dias JJ, Braybrooke J. Dupuytren's contracture: an audit of the outcomes of surgery. J Hand Surg Br 2006;31:514-21
15. Bainbridge C, Dahlin LB, Szczypa PP, et al. Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts. Eur Orthop Traumatol 2012;3:31-41
16. Hueston JT. 'Firebreak' grafts in Dupuytren's contracture. Aust N Z J Surg 1984;54:277-81
17. Ketchum LD, Hixson FP. Dermofasciectomy and full-thickness grafts in the treatment of Dupuytren's contracture. J Hand Surg Am 1987;12(5 Pt 1):659-64
18. Tonkin MA, Burke FD, Varian JP. Dupuytren's contracture: a comparative study of fasciectomy and dermofasciectomy in one hundred patients. J Hand Surg Br 1984;9:156-62
19. Ullah AS, Dias JJ, Bhowal B. Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture? A prospective, randomised trial. J Bone Joint Surg 2009;91:374-8
20. Crean SM, Gerber RA, Le Graverand MP, et al. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies. J Hand Surg Eur 2011;36:396-407
21. Au-Yong IT, Wildin CJ, Dias JJ, et al. A review of common practice in Dupuytren surgery. Tech Hand Up Extrem Surg 2005;9:178-87
22. Trojian TH, Chu SM. Dupuytren's disease: diagnosis and treatment. Am Fam Physician 2007;76:86-9
23. British Society for Surgery of the Hand (BSSH). BSSH Evidence for Surgical Treatment 1 (BEST 1): Dupuytren's Disease. March 2012. Available at: http://www.bssh.ac.uk/education/guidelines/dd-guidelines.pdf [Last accessed 23 July 2012]
24. Denkler K. Surgical complications associated with fasciectomy for Dupuytren's disease: a 20-year review of the English literature. Eplasty 2010;10:e15
25. van Rijssen AL, Ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstructr Surg 2012;129: 469-77
26. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990;265:659-65
27. Betz N, Ott OJ, Adamietz B, et al. Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years. Strahlenther Onkol 2010;186:82-90
28. Falter E, Herndl E, Mü hlbauer W. [Dupuytren's contracture. When operate? Conservative preliminary treatment?]. Fortschr Med 1991;109:223-6
29. Hurst LC, Badalamente MA. Nonoperative treatment of Dupuytren's disease. Hand Clin 1999;15:97-107, vii
30. Rayan GM. Nonoperative treatment of Dupuytren's disease. J Hand Surg Am 2008;33:1208-10
31. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am 2007;32:767-74
32. Gilpin D, Coleman S, Hall S, et al. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's contracture. J Hand Surg Am 2010;35A:2027-38
33. Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. New Engl J Med 2009;361:968-79
34. Dahlin LB, Bainbridge C, Szczypa PP, et al. Current trends in the surgical management of Dupuytren's disease in Europe: the surgeon's perspective. Eur Orthop Traumatol 2012;3:25-30
35. Rayan GM. Clinical presentation and types of Dupuytren's disease. Hand Clin 1999;15:87-96, vii
36. Rayan GM, Moore J. Non-Dupuytren's disease of the palmar fascia. J Hand Surg Br 2005;30:551-6
37. Hart MG, Hooper G. Clinical associations of Dupuytren's disease. Postgrad Med J 2005;81:425-8
38. Beaudreuil J, Allard A, Zerkak D, et al. Unite Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability. Arthritis Care Res (Hoboken) 2011;63:1448-55
39. Leclercq C. Clinical aspects. In: Tubiana R, Leclercq C, Hurst L, et al. Dupuytren's Disease. London: Martin Dunitz Ltd, 2000:86
40. Loos B, Puschkin V, Horch RE. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital-a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord 2007;8:1-9
41. National Institute for Clinical Excellence Interventional Procedures Programme. Interventional procedures overview of needle fasciotomy for Dupuytren's contracture. 2003: 1-10. Available at: http://www.nice.org.uk/ nicemedia/live/11116/31122/31122.pdf [Last accessed 23 July 2012]
42. van Middelkoop M, Huisstede BM, Glerum S, et al. Effectiveness of interventions of specific complaints of the arm, neck, or shoulder (CANS): musculoskeletal disorders of the hand. Clin J Pain 2009;25:537-52
43. Hueston JT. The Dupuytren's diathesis. In: Hueston JT, ed. Dupuytren's Contracture. Edinburgh: Churchill Livingstone, 1963:51-63
44. Draviaraj KP, Chakrabarti I. Functional outcome after surgery for Dupuytren's contracture: a prospective study. J Hand Surg Am 2004;29:804-8
45. Sinha R, Cresswell TR, Mason R, et al. Functional benefit of Dupuytren's surgery. J Hand Surg Br 2002;27:378-81
46. Peimer CA, Pess G, Skodny P, et al. Use of collagenase Clostridium histolyticum in earlier vs. advanced stage Dupuytren's Contracture results in better outcomes (abstr A-0176). J Hand Surg Eur 2012;37(1 suppl):S1-84